awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36073707-13EA1B83-894E-4709-9695-E52A1265F6CA
Q36073707-13EA1B83-894E-4709-9695-E52A1265F6CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36073707-13EA1B83-894E-4709-9695-E52A1265F6CA
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer
P2860
Q36073707-13EA1B83-894E-4709-9695-E52A1265F6CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36073707-13EA1B83-894E-4709-9695-E52A1265F6CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a529bf2711ffba71e7b9699c96fbf9409e345a06
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.